Tickers

1. Composite Trajectory Verdict

Given EOG's capital-intensive exploration and production model and its explicit cash-return framework (minimum 70% of operating cash flow less capex), all three statements — income, cash flow, and balance sheet — carry roughly equal weight in assessing financial trajectory.

Composite Trajectory: Mixed

Annual results through 2025 show deteriorating trends: revenue, net income, and operating cash flow each declined year-over-year, while debt rose sharply and cash fell by more than half. However, the first half of 2026 shows a sharp reversal: quarterly and year-to-date revenues surged over 35% year-over-year, operating cash flow jumped 77%, and the balance sheet improved with cash rising $1.5 billion and the debt-to-capitalization ratio edging down to 20%. The annual and interim trajectories point in opposite directions, resulting in a mixed overall picture.

2. Red Flags

• Net income declined for three consecutive years: $7,594 million (2023) → $6,403 million (2024) → $4,980 million (2025) (10-K 2025, Consolidated Statements of Operations).
• Operating cash flow fell 17% in 2025 to $10,044 million from $12,143 million in 2024 (10-K 2025, Consolidated Statements of Cash Flows).
• Total debt increased 67% in 2025 to $7,936 million from $4,752 million in 2024, driven by $3.5 billion of senior notes issued to fund the Encino acquisition (10-K 2025, Consolidated Balance Sheets; 10-K 2025, MD&A).
• Cash and cash equivalents dropped 52% in 2025 to $3,396 million from $7,092 million in 2024 (10-K 2025, Consolidated Balance Sheets).
• Proved property impairments surged to $709 million in 2025 from $295 million in 2024, primarily in the Barnett Shale and Woodford Oil Window (10-K 2025, MD&A).
• Net gains on mark-to-market derivatives collapsed to $13 million in 2025 from $204 million in 2024, with net cash settlements turning to a $56 million outflow from a $214 million inflow (10-K 2025, MD&A; 10-K 2025, Consolidated Statements of Cash Flows).
• General and administrative expenses rose 22% in 2025 to $820 million, including $100 million of Encino acquisition-related costs (10-K 2025, MD&A).
• Interest expense, net, increased 70% in 2025 to $235 million from $138 million due to new note issuances (10-K 2025, MD&A).
• Share repurchases remained elevated at $2.6 billion in 2025 despite declining operating cash flow and rising debt (10-K 2025, Consolidated Statements of Cash Flows).

3. Earnings Assessment (Income Statement)

Earnings Trajectory: Mixed

Annual GAAP net income declined each year from 2023 ($7,594 million) to 2024 ($6,403 million) to 2025 ($4,980 million), with revenue falling from $24,186 million to $23,698 million to $22,632 million over the same period (10-K 2025, Consolidated Statements of Operations). Operating income followed the same pattern: $9,603 million → $8,082 million → $6,385 million. In contrast, the first half of 2026 shows a strong year-over-year rebound: six-month revenue rose 39% to $15,541 million from $11,147 million, driven by a 36% increase in production revenues to $11,745 million (10-Q Q2 2026, MD&A). The quarterly comparison is even starker: Q2 2026 revenue of $8,620 million was 57% above Q2 2025's $5,478 million (10-Q Q2 2026, Condensed Consolidated Statements of Operations). While the annual trend is clearly deteriorating, the most recent interim period shows substantial improvement.

4. Cash Generation Assessment (Statement of Cash Flows)

Cash Trajectory: Mixed

Full-year operating cash flow peaked at $12,143 million in 2024 before falling to $10,044 million in 2025, a 17% decline attributed to higher cash taxes, higher cash operating expenses, adverse derivative settlements, and working capital outflows (10-K 2025, MD&A; 10-K 2025, Consolidated Statements of Cash Flows). Investing cash outflows more than doubled to $10,936 million in 2025 due primarily to the $4,451 million Encino acquisition (10-K 2025, Consolidated Statements of Cash Flows). Financing cash outflows moderated to $2,804 million in 2025 from $4,361 million in 2024, as debt issuances ($4,471 million) largely offset share repurchases ($2,564 million) and debt repayments ($2,516 million). For the first half of 2026, operating cash flow rebounded sharply to $7,635 million, up 77% from the comparable 2025 period ($4,321 million implied), driven by higher production revenues, lower cash taxes, and improved working capital (10-Q Q2 2026, MD&A). Investing outflows were roughly flat at $3,326 million, while financing outflows of $2,798 million reflected continued share repurchases ($1,717 million) and dividends ($1,084 million) (10-Q Q2 2026, MD&A).

5. Balance Sheet Assessment

Balance Sheet Trajectory: Mixed

At December 31, 2025, total assets stood at $51,799 million, up from $47,186 million a year earlier, largely reflecting the Encino acquisition (10-K 2025, Consolidated Balance Sheets). Total debt (current plus long-term) rose to $7,936 million from $4,752 million, pushing the debt-to-total-capitalization ratio to 21% from 14% (10-K 2025, MD&A). Cash fell to $3,396 million from $7,092 million. Stockholders' equity was essentially flat at $29,833 million versus $29,351 million. By June 30, 2026, the picture improved: cash rose to $4,907 million, total debt was nearly unchanged at $7,926 million, equity increased to $31,864 million, and the debt-to-capitalization ratio declined to 20% (10-Q Q2 2026, Consolidated Balance Sheets; 10-Q Q2 2026, MD&A). The annual comparison shows leverage up and liquidity down; the interim comparison shows the reverse.

6. Data Gaps

• Quarterly GAAP net income and operating income for Q2 2026 and Q2 2025 are not explicitly disclosed in the provided 10-Q excerpts; only income tax expense and effective tax rates are given, requiring derivation.
• Full 10-Q filings for Q1 2026 (2026-03-31), Q3 2025 (2025-09-30), and Q2 2025 (2025-06-30) were listed as provided but their contents are not included in the text, limiting quarterly trend analysis to a single quarter-over-quarter comparison.
• Free cash flow (operating cash flow minus capital expenditures) is not directly reported for any period; capex is reported in the MD&A tables but not reconciled to the cash flow statement's investing section in the excerpts.
• Segment-level income statement detail (e.g., operating income by segment) for the 2026 interim periods is not fully presented in the provided XBRL or MD&A tables.
• Realized derivative gains/losses broken out by commodity for the 2026 interim periods are only partially disclosed in the MD&A narrative.